Table 1.
DR4+ RA twin | DR4+ healthy twin | DR3+ RA patient | |
---|---|---|---|
CM CD4 T cells (%): unstimulated | 82·9 | 87·8 | 74·2 |
T261–273 | 81·9 | 84·2 | 81·2 |
carT261–273 | 85·4 | 83·5 | 77·0 |
T261–273+B359–369 | 85·0 | 81·3 | 63·1 |
carT261–273+citB359–369 | 83·2 | 83·0 | 81·3 |
EM CD4 T cells (%): unstimulated | 15·3 | 10·8 | 23·8 |
T261–273 | 16·5 | 14·6 | 16·5 |
carT261–273 | 13·4 | 14·4 | 18·3 |
T261–273+B359–369 | 14·2 | 17·2 | 34·2 |
carT261–273+citB359–369 | 15·7 | 15·0 | 14·3 |
CCR7 CD4 T cells (MFI): unstimulated | 1099 | 1822 | 1835 |
T261–273 | 6370 | 6781 | 1828 |
carT261–273 | 6845 | 5688 | 1854 |
T261–273+B359–369 | 6828 | 5796 | 1946 |
carT261–273+citB359–369 | 6388 | 6582 | 1847 |
CD69 B cells (%): unstimulated | 17·3 | 16·0 | 47·2 |
B359–369 | 24·3 | 21·4 | 38·6 |
citB359–369 | 24·9 | 36·3 | 28·6 |
T261–273+B359–369 | 22·9 | 46·9 | 28·0 |
carT261–273+citB359–369 | 29·9 | 46·1 | 34·0 |
CD69 B cells (MFI): unstimulated | 583 | 570 | 812 |
B359–369 | 653 | 354 | 786 |
citB359–369 | 659 | 803 | 606 |
T261–273+B359–369 | 639 | 809 | 600 |
carT261–273+citB359–369 | 709 | 801 | 780 |